Circulating oxidized LDL is associated with the occurrence of echolucent plaques in the carotid artery in 61‐year‐old men

References

• Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med 1999; 340: 115–26
   PubMed Web of Science ®Google Scholar
• Brown M. S., Goldstein J. L. Atherosclerosis. Scavenging for receptors. Nature 1990; 343: 508–9
   PubMed Web of Science ®Google Scholar
• Ridker P. M., Hennekens C. H., Buring J. E., Rifai N. C‐reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836–43
   PubMed Web of Science ®Google Scholar
• Holvoet P., Mertens A., Verhamme P., et al. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2001; 21: 844–8
   PubMed Web of Science ®Google Scholar
• Wallenfeldt K., Fagerberg B., Wikstrand J., Hulthe J. Oxidized low‐density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men. J Intern Med 2004; 256: 413–20
   PubMed Web of Science ®Google Scholar
• Mann J. M., Davies M. J. Vulnerable plaque. Relation of characteristics to degree of stenosis in human coronary arteries. Circulation 1996; 94: 928–31
   PubMed Web of Science ®Google Scholar
• Wikstrand J., Wiklund O. Frontiers in cardiovascular science. Quantitative measurements of atherosclerotic manifestations in humans. Arterioscler Thromb 1992; 12: 114–19
   PubMed Web of Science ®Google Scholar
• Gray‐Weale A. C., Graham J. C., Burnett J. R., Byrne K., Lusby R. J. Carotid artery atheroma: comparison of preoperative B‐mode ultrasound appearance with carotid endarterectomy specimen pathology. J Cardiovasc Surg (Torino) 1988; 29: 676–81
   PubMed Web of Science ®Google Scholar
• El‐Barghouty N. M., Levine T., Ladva S., Flanagan A., Nicolaides A. Histological verification of computerised carotid plaque characterisation. Eur J Vasc Endovasc Surg 1996; 11: 414–16
   PubMed Web of Science ®Google Scholar
• Schmidt C., Fagerberg B., Wikstrand J., Hulthe J. Multiple risk factor intervention reduces cardiovascular risk in hypertensive patients with echolucent plaques in the carotid artery. J Intern Med 2003; 253: 430–8
   PubMed Web of Science ®Google Scholar
• Mathiesen E. B., Bonaa K. H., Joakimsen O. Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: the Tromsø study. Circulation 2001; 103: 2171–5
   PubMed Web of Science ®Google Scholar
• Ridker P. M., Buring J. E., Cook N. R., Rifai N. C‐reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8‐year follow‐up of 14 719 initially healthy American women. Circulation 2003; 107: 391–7
   PubMed Web of Science ®Google Scholar
• Hulthe J., Bokemark L., Wikstrand J., Fagerberg B. The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) study. Arterioscler Thromb Vasc Biol 2000; 20: 2140–7
   PubMed Web of Science ®Google Scholar
• Sigurdardottir V., Fagerberg B., Hulthe J. Preclinical atherosclerosis and inflammation in 61‐year‐old men with newly diagnosed diabetes and established diabetes. Diabetes Care 2004; 27: 880–4
   PubMed Web of Science ®Google Scholar
• Bokemark L., Wikstrand J., Wedel H., Fagerberg B. Insulin, insulin propeptides and intima‐media thickness in the carotid artery in 58‐year‐old clinically healthy men. The atherosclerosis and insulin resistance study (AIR). Diabetes Med 2002; 19: 144–51
   PubMed Web of Science ®Google Scholar
• Hulthe J., Wikstrand J., Fagerberg B. Relationship between C‐reactive protein and intima‐media thickness in the carotid and femoral arteries and to antibodies against oxidized low‐density lipoprotein in healthy men: the atherosclerosis and insulin resistance (AIR) study. Clin Sci (Lond) 2001; 100: 371–8
   PubMed Web of Science ®Google Scholar
• Hulthe J., Fagerberg B. Circulating oxidized LDL is associated with increased levels of cell‐adhesion molecules in clinically healthy 58‐year‐old men (AIR study). Med Sci Monit 2002; 8: CR148–52
   PubMedGoogle Scholar
• Holvoet P., Stassen J. M., Van Cleemput J., Collen D., Vanhaecke J. Oxidized low density lipoproteins in patients with transplant‐associated coronary artery disease. Arterioscler Thromb Vasc Biol 1998; 18: 100–7
   PubMed Web of Science ®Google Scholar
• Wendelhag I., Wiklund O., Wikstrand J. Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia. Ultrasonographic assessment of intima‐media thickness and plaque occurrence. Arterioscler Thromb 1993; 13: 1404–11
   PubMed Web of Science ®Google Scholar
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc 2001; 285: 2486–97
   PubMed Web of Science ®Google Scholar
• Zureik M., Bureau J. M., Temmar M., et al. Echogenic carotid plaques are associated with aortic arterial stiffness in subjects with subclinical carotid atherosclerosis. Hypertension 2003; 41: 519–27
   PubMed Web of Science ®Google Scholar
• Held C., Hjemdahl P., Eriksson S. V., Bjorkander I., Forslund L., Rehnqvist N. Prognostic implications of intima‐media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris. Eur Heart J 2001; 22: 62–72
   PubMed Web of Science ®Google Scholar
• Gronholdt M. L., Nordestgaard B. G., Schroeder T. V., Vorstrup S., Sillesen H. Ultrasonic echolucent carotid plaques predict future strokes. Circulation 2001; 104: 68–73
   PubMed Web of Science ®Google Scholar
• Chapman C. M., Beilby J. P., McQuillan B. M., Thompson P. L., Hung J. Monocyte count, but not C‐reactive protein or interleukin‐6, is an independent risk marker for subclinical carotid atherosclerosis. Stroke 2004; 35: 1619–24
   PubMed Web of Science ®Google Scholar
• Muscari A., Martignani C., Bastagli L., et al. A comparison of acute phase proteins and traditional risk factors as markers of combined plaque and intima‐media thickness and plaque density in carotid and femoral arteries. Eur J Vasc Endovasc Surg 2003; 26: 81–7
   PubMed Web of Science ®Google Scholar
• Sigurdardottir V., Fagerberg B., Wikstrand J., Schmidt C., Hulthe J. Circulating oxidized low‐density lipoprotein is associated with echolucent plaques in the femoral artery independently of hsCRP in 61‐year old men. Atherosclerosis 2007 Jan; 190: 187–93
   PubMed Web of Science ®Google Scholar
• Rothwell P. M., Villagra R., Gibson R., Donders R. C., Warlow C. P. Evidence of a chronic systemic cause of instability of atherosclerotic plaques. Lancet 2000; 355: 19–24
   PubMed Web of Science ®Google Scholar
• Goldstein J. A., Demetriou D., Grines C. L., Pica M., Shoukfeh M., O'Neill W. W. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 2000; 343: 915–22
   PubMed Web of Science ®Google Scholar
• Polak J. F., Shemanski L., O'Leary H., et al. Hypoechoic plaque at US of the carotid artery: an independent risk factor for incident stroke in adults aged 65 years or older. Cardiovascular Health Study. Radiology 1998; 208: 649–54
   PubMed Web of Science ®Google Scholar